Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parameters

[1]  J. Bone,et al.  Plasma thrombomodulin in renal disease: effects of renal function and proteinuria. , 1998, Clinical nephrology.

[2]  H. Peter,et al.  Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus , 1998, Rheumatology International.

[3]  S. Mezzano,et al.  Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure. , 1997, Thrombosis research.

[4]  H. Deicher,et al.  Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus , 1997, Journal of Neurology.

[5]  M. Hochberg.  AMERICAN COLLEGE OF RHEUMATOLOGY REVISED CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS , 1997 .

[6]  S. Aotsuka,et al.  Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic diseases. , 1997, Clinical and experimental rheumatology.

[7]  M. Boffa,et al.  Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker? , 1996, Haemostasis.

[8]  M. Yoshida,et al.  Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis. , 1995, Research communications in molecular pathology and pharmacology.

[9]  N. Yanagisawa,et al.  Thrombomodulin in the sera of patients with multiple sclerosis and human lymphotropic virus type-1-associated myelopathy , 1995, Journal of Neuroimmunology.

[10]  W. Scherbaum,et al.  Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. , 1994, Arthritis and rheumatism.

[11]  S. Ohdama,et al.  Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. , 1994, American journal of clinical pathology.

[12]  P. Schneider,et al.  Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. , 1992, The Journal of clinical investigation.

[13]  H. Niwano,et al.  Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von willebrand factor and tissue‐type plasminogen activator , 1992, American journal of hematology.

[14]  J. Hanly,et al.  Brain pathology in systemic lupus erythematosus. , 1992, The Journal of rheumatology.

[15]  J. Piette,et al.  Increase in plasma thrombomodulin in lupus erythematosus with antiphospholipid antibodies. , 1992, Blood.

[16]  K. Watanabe,et al.  Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. , 1991, Clinical and experimental rheumatology.

[17]  H. Ishii,et al.  Increased thrombomodulin values in plasma of diabetic men with microangiopathy. , 1991, Clinical chemistry.

[18]  S. Kimura,et al.  Plasma thrombomodulin in health and diseases. , 1990, Blood.

[19]  T. Ishikawa,et al.  Establishment of Enzyme Immunoassay of Human Thrombomodulin in Plasma and Urine Using Monoclonal Antibodies , 1990, Thrombosis and Haemostasis.

[20]  O. Devinsky,et al.  Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura , 1988, Annals of neurology.

[21]  P. Majerus,et al.  Thrombomodulin is present in human plasma and urine. , 1985, The Journal of clinical investigation.

[22]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[23]  C. Esmon,et al.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, Proceedings of the National Academy of Sciences of the United States of America.